Skip directly to content

CME Programs

Expired Programs

Diabetes: A Global Epidemic

This program is no longer available for CME credit.

Discovery Health CME has traveled the globe to produce a first-ever continuing medical education documentary revealing the impact the globalization of the world has had on the incidence and prevalence of diabetes, and the economic and human toll of this rising epidemic.

With Discovery Health cameras following, leading diabetes authority Francine R. Kaufman, M.D. visited India, Australia, Brazil, Africa, Europe and North America, having discussions with physicians, patients and diabetes thought leaders on the challenges and success stories of this newest epidemic.

The result is an hour of Continuing Medical Education so compelling and real that physicians will have a whole new understanding for the way diabetes has grown worldwide, and appreciation for the resources we have in the United States for its care. The program focuses not so much on the state of the science in diabetes care, but more on the relationship between the cultures of the countries visited and the global epidemic of diabetes.

Effectively Managing Anticoagulation

This program is no longer available for CME credit.

Chronic anticoagulation is indicated in the management of a number of medical conditions. However, warfarin has a narrow therapeutic window and requires regular monitoring to maintain efficacy and lower the risk of complications. Traditional office-based anticoagulation management has a number of practical and medical disadvantages.

The use of point of care testing has been shown to increase time in therapeutic range and decrease complications. Discovery Health has assembled a group of experts to discuss the benefits of point-of-care testing, the accuracy and precision of point-of-care instruments, and the appropriate patients for self-monitoring and self-management.

Aspirin Therapy: Maximizing the Benefits

This program is no longer available for CME credit.

Aspirin plays a significant role in primary and secondary prevention of myocardial infarction, stroke, and cardiovascular death due to its action as an inhibitor of platelet function. Aspirin therapy is recommended for certain patients in guidelines by the American Heart Association, the American College of Cardiology, and the American Diabetes Association. Adherence to these guidelines is considered a measure of quality by many organizations.

Despite national guidelines, aspirin therapy continues to be underused and under-prescribed. Education on the current research and clinical guidelines about aspirin therapy will serve to improve utilization of this low-cost high-benefit medication.

Discovery Health has assembled a panel of thought leaders to discuss the data associated with the effective use of aspirin, its indications, benefits and associated risks, as well as issues with misconceptions about aspirin and physician compliance with clinical guidelines for its use.

Insulin Initiation: Targeting Type 2 Diabetes

This program is no longer available for CME credit.

Type 2 diabetes has become an epidemic in the United States. Despite effective medications and clinical guidelines, glycemic control continues to be inadequate. For many patients, the early initiation of insulin may them achieve their glycemic targets. Despite current recommendations advocating insulin therapy in type 2 diabetes, there are both patient and physician barriers to instituting an insulin regimen.

Discovery Health has assembled a panel of experts to review the recent scientific evidence relating to the pathophysiology of type 2 diabetes, the benefits of early insulin therapy, and the current recommendations for insulin initiation in type 2 diabetes.

Improving Glycemic Control with Postprandial Glucose Monitoring

This program is no longer available for CME credit.

Blood glucose monitoring is an important tool in the achievement of glycemic control in the diabetic population. Postprandial glucose monitoring is an effective measure with which many physicians are unfamiliar. By incorporating postprandial glucose measurements into the overall strategy of diabetic management, physicians can more effectively manage diabetic patients and minimize complications.

Discovery Health CME has engaged a panel of experts to discuss the incorporation of PPG monitoring into the management of diabetic patients.

Restless Legs Syndrome: Calming the Storm

This program is no longer available for CME credit.

Restless legs syndrome (RLS) is a very common condition in the United States, yet it is persistently under-diagnosed and under-treated. The syndrome is associated with dramatic effects on quality of life due to sleep deficiency. This sleep deficiency results in fatigue, difficulty concentrating, and is associated with depression. Although the pathophysiology of RLS is not completely understood, there are effective therapies available for patients suffering from this syndrome.

Discovery Health has assembled a panel of thought leaders on RLS to discuss the epidemiology, symptoms, diagnostic criteria, pathophysiology, and therapies that have proven successful in its treatment.

The Premenstrual Continuum: Improving Diagnosis and Treatment

This program is no longer available for CME credit.

Premenstrual syndrome (PMS) and its more severe variant premenstrual dysphoric disorder (PMDD) are common conditions in the United States. These two syndromes, which devise the premenstrual continuum, are under-diagnosed, under-treated, and associated with significant disability. Given the repetitive nature of the premenstrual symptoms, timely diagnosis and appropriate treatment are crucial.

Discovery Health has assembled a panel of experts to discuss clinical presentation of PMS and PMDD, diagnostic criteria, and new treatment options in The Premenstrual Continuum: Improving Diagnosis and Treatment.

Hematologic Malignancies: Improving Outcomes with New Treatments

This program is no longer available for CME credit.

Discovery Channel presents an all new Continuing Medical Education program focused on helping physicians understand the spectrum of hematologic disorders including leukemias and multiple myeloma, identify therapeutic choices, formulate an evidence-based approach to these choices and identify patients who would benefit.  Led by a panel of experts, the program will include discussion about untreated and undertreated hematologic disorders, highlight treatment updates, and explain outcomes and monitoring measures for patients receiving these treatments.

Pages